Edward van der Horst
2022
In 2022, Edward van der Horst earned a total compensation of $654.4K as Chief Scientific Officer at Sensei Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $103,543 |
|---|---|
| Option Awards | $146,327 |
| Salary | $326,923 |
| Stock Awards | $63,210 |
| Other | $14,401 |
| Total | $654,404 |
der Horst received $326.9K in salary, accounting for 50% of the total pay in 2022.
der Horst also received $103.5K in non-equity incentive plan, $146.3K in option awards, $63.2K in stock awards and $14.4K in other compensation.
Rankings
In 2022, Edward van der Horst's compensation ranked 3,881st out of 5,676 executives tracked by ExecPay. In other words, der Horst earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,881 out of 5,676 | 32nd |
Division Manufacturing | 2,193 out of 3,084 | 29th |
Major group Chemicals And Allied Products | 1,062 out of 1,399 | 24th |
Industry group Drugs | 996 out of 1,300 | 23rd |
Industry Pharmaceutical Preparations | 727 out of 942 | 23rd |
Source: SEC filing on June 15, 2023.
der Horst's colleagues
We found three more compensation records of executives who worked with Edward van der Horst at Sensei Biotherapeutics in 2022.